- Home
- TC vs CLNN Comparison
TC vs CLNN Comparison
Compare TC & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- CLNN
- Stock Information
- Founded
- TC 2010
- CLNN 2012
- Country
- TC China
- CLNN United States
- Employees
- TC N/A
- CLNN N/A
- Industry
- TC Business Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- TC Consumer Discretionary
- CLNN Health Care
- Exchange
- TC Nasdaq
- CLNN Nasdaq
- Market Cap
- TC 26.0M
- CLNN 23.1M
- IPO Year
- TC 2018
- CLNN N/A
- Fundamental
- Price
- TC $0.58
- CLNN $3.62
- Analyst Decision
- TC
- CLNN Strong Buy
- Analyst Count
- TC 0
- CLNN 5
- Target Price
- TC N/A
- CLNN $40.00
- AVG Volume (30 Days)
- TC 438.2K
- CLNN 71.6K
- Earning Date
- TC 08-29-2025
- CLNN 08-14-2025
- Dividend Yield
- TC N/A
- CLNN N/A
- EPS Growth
- TC N/A
- CLNN N/A
- EPS
- TC N/A
- CLNN N/A
- Revenue
- TC $6,737,269.00
- CLNN $286,000.00
- Revenue This Year
- TC N/A
- CLNN N/A
- Revenue Next Year
- TC N/A
- CLNN $1,753.57
- P/E Ratio
- TC N/A
- CLNN N/A
- Revenue Growth
- TC N/A
- CLNN N/A
- 52 Week Low
- TC $0.46
- CLNN $2.28
- 52 Week High
- TC $4.30
- CLNN $6.90
- Technical
- Relative Strength Index (RSI)
- TC 34.47
- CLNN 47.10
- Support Level
- TC $0.52
- CLNN $3.50
- Resistance Level
- TC $0.89
- CLNN $3.86
- Average True Range (ATR)
- TC 0.07
- CLNN 0.19
- MACD
- TC -0.01
- CLNN 0.01
- Stochastic Oscillator
- TC 16.22
- CLNN 60.66
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.